4//SEC Filing
Pande Atul 4
Accession 0001764013-24-000200
CIK 0001764013other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:22 PM ET
Size
6.2 KB
Accession
0001764013-24-000200
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Pande Atul
Director
Transactions
- Sale
Common Stock
2024-12-02$28.54/sh−7,750$221,185→ 86,663 total
Holdings
- 20,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale of shares of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023 in order to satisfy applicable tax obligations arising in connection with the vesting and deferred settlement of a prior award of restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.03 - $29.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001643071
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:22 PM ET
- Size
- 6.2 KB